A Shifting Landscape: New Strategies for Diagnostic Access & Adoption

  • Establishing a foundation for market access through in-country clinical utility studies and operational investment
  • Utilizing AI-powered digital pathology to create a more efficient and cost-effective path to NGS testing
  • Pioneering collaborative commercial models to remove access barriers and accelerate diagnostic adoption